Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 66,115,361
- Total 13F value
- $48,286,884
- Share change
- -2,547,504
- SEC-reported price per share
- $0.73
- Number of holders
- 55
- Value change
- -$1,938,715
- Number of buys
- 14
- Number of sells
- 30
- Shares outstanding
- 28,495,649
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
55
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 82%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 82%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
82%
PURA VIDA INVESTMENTS, LLC
63%
AWM Investment Company, Inc.
27%
VANGUARD GROUP INC
15%
ORBIMED ADVISORS LLC
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
82%
|
$21,011,000
23,353,697 shares
|
— | 30 Jun 2022 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
63%
|
$16,245,000
18,056,274 shares
|
— | 30 Jun 2022 |
| AWM Investment Company, Inc. |
13F
Company
|
27%
|
$6,970,000
7,746,557 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
15%
|
$3,911,000
4,346,530 shares
|
— | 30 Jun 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
10%
|
$2,553,000
2,837,800 shares
|
— | 30 Jun 2022 |
| Defender Capital, LLC. |
13F
Company
|
9.1%
|
$2,330,000
2,589,380 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
55
Shares
66,115,361
Rows available
55
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
64
Q3 2022 holders
55
Holder diff
-9
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend